Clinical Trials Directory

Trials / Terminated

TerminatedNCT00000309

Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1

Serotonin/Dopamine Antagonism of Cocaine Effect

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
Butler Hospital · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.

Conditions

Interventions

TypeNameDescription
DRUGRisperidone

Timeline

Start date
1994-08-01
Primary completion
2000-01-01
Completion
2000-01-01
First posted
1999-09-21
Last updated
2015-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000309. Inclusion in this directory is not an endorsement.

Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 (NCT00000309) · Clinical Trials Directory